Phil and Judy Messing: OCRF Partners in Science
Phil and Judy Messing: OCRF Partners in Science
Phil and Judy Messing knew they wanted to support ovarian cancer research in memory of their daughter.
News
Stand Up to Cancer Returns to Primetime on Friday, Septembe...
Stand Up to Cancer Returns to Primetime on Friday, September 5 for its Fourth Star-Studded Broadcast
LIVE, ONE-HOUR FUNDRAISING EVENT TO AIR SIMULTANEOUSLY ON ABC, CBS, FOX, NBC AND 26 BROADCAST AND CABLE NETWORKS 8 PM ET & PT / 7PM CT Broadcast Coincides with Live … Continued
OCRF Research Shows ARID1A is Tumor Suppressor Gene
OCRF Research Shows ARID1A is Tumor Suppressor Gene
(July 8, 2014) Frequent mutations in the ARID1A gene have been previously discovered in ovarian endometrioid and clear-cell cancers. Now research supported by OCRF has provided direct evidence that it … Continued
Kelly Ripa and Donna Karan to Host Ovarian Cancer Research ...
Kelly Ripa and Donna Karan to Host Ovarian Cancer Research Fund’s Super Saturday 17
WORLD FAMOUS DESIGNER GARAGE SALE SPONSORED BY QVC SATURDAY, JULY 26TH IN WATERMILL, NY NEW YORK, N.Y. – July 8, 2014 – Kelly Ripa and Donna Karan will host Ovarian … Continued
Q&A with OCRF Grantee John Weroha, MD, PhD
Q&A with OCRF Grantee John Weroha, MD, PhD
Q&A with John Weroha, MD, PhD 2014 Liz Tilberis Early Career Award Mayo Clinic Were you always in interested in science? By the … Continued
No Link Between Fertility Drugs and Breast, Ovarian and Ute...
No Link Between Fertility Drugs and Breast, Ovarian and Uterine Cancers
(July 1, 2014) There is “little evidence” that the use of conventional fertility hormones used for ovarian stimulation in the treatment of infertility increases the long-term risk of breast and … Continued
Pelvic Exam Guidelines
Pelvic Exam Guidelines
The American College of Physicians recently recommended that women do not need to have a pelvic exam on an annual basis. Current evidence suggests that the pelvic exam is not helpful as a routine screening test for women with an average risk of developing ovarian cancer.
Partner Member Profile
Partner Member Profile
2015 marks the 15th anniversary of the Wisconsin Ovarian Cancer Alliance (WOCA), a Partner Member organization dedicated to overcoming ovarian cancer through education, advocacy, and awareness. When oncology nurse Joan Sagan was diagnosed with stage 3C ovarian cancer in 1999, she, along with sisters Kelli Zembruski and Sandi Wagner, realized there was an immediate need for ovarian cancer education in their home state of Wisconsin. While Joan knew from her role as an oncology nurse how devastating this disease can be, Kelli and Sandi knew very little about ovarian cancer. At this point, ovarian cancer was still known as the silent killer, with no symptom awareness. In May 2000, the Wisconsin Ovarian Cancer Alliance was officially founded, with the mission to educate the community about ovarian cancer and raise awareness about this horrible disease. Click the plus sign to read more.
Palliative Care at Time of Cancer Diagnosis Improves Survival
Palliative Care at Time of Cancer Diagnosis Improves Survival
(June 25, 2014) Research presented at the annual meeting of the American Society of Clinical Oncology earlier this month suggests that palliative care delivered at the time of cancer diagnosis … Continued
Gemcitabine, Carboplatin, and Bevacizumab Extend PFS
Gemcitabine, Carboplatin, and Bevacizumab Extend PFS
(June 24, 2014) Earlier this month, researchers reported results of a Phase II trial which looked at efficacy and safety of a biweekly gemcitabine, carboplatin, and bevacizumab combination in patients … Continued
Webinar Highlights Research News from ASCO
Webinar Highlights Research News from ASCO
On Monday, June 16, 2014, Dr. Douglas Levine of Memorial Sloan Kettering Cancer Center presented a free webinar focusing on research news that was presented at 2014’s medical meetings. In … Continued
Report from the 2014 American Society of Clinical Oncology ...
Report from the 2014 American Society of Clinical Oncology Annual Meeting
Promising new combination treatments for ovarian cancer Dr. Joyce Liu, MD, on behalf of researchers from the National Cancer Institute (NCI) and Dana Farber Cancer Institute (DFCI), presented striking results … Continued